|
2026 Journal Article Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumorsTu, Cui, Tan, Chin Wee, Monkman, James, Almeida, Ana Clara, Antonio-Carreon, Gabrielle, Omer, Natacha, Hull, Giaan, Chung, Kimberly, Mehdi, Ahmed M., Salerno, Antonietta, Vittorio, Orazio, Mayer, Aaron, Machado-Souza, Cleber, Jayabalan, Nanthini, Toh, Yi-Chin, Hon, Hui Nee, de Almeida Brehm Pinhatti, Fernanda, Elifio-Esposito, Selene, Nicholls, Wayne, de Noronha, Lucia, Kulasinghe, Arutha and Souza-Fonseca-Guimaraes, Fernando (2026). Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors. Genome Medicine, 18 (1) 35. doi: 10.1186/s13073-026-01622-0 |
|
2026 Journal Article Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapyWong, Joshua K. M., Lam, Pui Yeng, Coleborn, Elaina, Alim, Louisa, Jose, Jiya, Tu, Cui, Antczak, Magdalena, Dietmair, Bettina, Hagh, Arghavan Golbaz, Noronha, Lucia, Cheetham, Seth W., Hooper, John, Beavis, Paul A., Merino, Delphine, Berthelet, Jean, Aoude, Lauren G., McCart-Reed, Amy E., Lakhani, Sunil, Simpson, Peter T., Rossi, Gustavo R., Brooks, Andrew J., Jones, Martina L., Simpson, Fiona and Souza-Fonseca-Guimaraes, Fernando (2026). Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy. Molecular Therapy, 34 (3), 1382-1398. doi: 10.1016/j.ymthe.2025.11.021 |
|
2025 Journal Article Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CARLam, Pui Yeng, Omer, Natacha, Wong, Josh K. M., Tu, Cui, Alim, Louisa, Rossi, Gustavo R., Victorova, Maria, Tompkins, Hannah, Lin, Cheng-Yu, Mehdi, Ahmed M., Choo, Amos, Elliott, Melissa R., Coleborn, Elaina, Sun, Jane, Mercer, Timothy, Vittorio, Orazio, Dobson, Lachlan J., Mclellan, Alexander D., Brooks, Andrew, Tuong, Zewen Kelvin, Cheetham, Seth W., Nicholls, Wayne and Souza-Fonseca-Guimaraes, Fernando (2025). Enhancement of anti-sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2-targeted CAR. Clinical and Translational Medicine, 15 (1) e70140, 1-21. doi: 10.1002/ctm2.70140 |
|
2024 Journal Article Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosisTu, Cui, Buckle, Irina, Leal Rojas, Ingrid, Rodrigues Rossi, Gustavo, Sester, David P., Moore, Andrew S., Radford, Kristen, Guillerey, Camille and Souza‐Fonseca‐Guimaraes, Fernando (2024). Exploring NK cell receptor dynamics in paediatric leukaemias: implications for immunotherapy and prognosis. Clinical and Translational Immunology, 13 (3) e1501, 1-15. doi: 10.1002/cti2.1501 |
|
2024 Journal Article Leveraging spatial omics for the development of precision sarcoma treatmentsTu, Cui, Kulasinghe, Arutha, Barbour, Andrew and Souza-Fonseca-Guimaraes, Fernando (2024). Leveraging spatial omics for the development of precision sarcoma treatments. Trends in Pharmacological Sciences, 45 (2), 134-144. doi: 10.1016/j.tips.2023.12.006 |
|
2022 Journal Article Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMACasey, Mika, Tu, Cui, Harrison, Simon J. and Nakamura, Kyohei (2022). Invariant NKT cells dictate antitumor immunity elicited by a bispecific antibody cotargeting CD3 and BCMA. Blood Advances, 6 (17), 5165-5170. doi: 10.1182/bloodadvances.2022008118 |
